Capricor Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of CAPR for the last quarter is 4.91 M USD, and it's 59.41% lower compared to the previous quarter. The net income of Q1 24 is -9.79 M USD.